ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the pricing of $200 million aggregate principal amount of its 3.625% convertible senior notes due 2019 (the “Notes”) in a private placement. The Notes will be offered by the initial purchasers only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). ARIAD also granted the initial purchasers of the Notes an option, exercisable for 30 days, to purchase up to an additional $30 million aggregate principal amount of the Notes on the same terms and conditions. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened today at $6.65 and is currently trading at $6.64. The stock showed a positive weekly performance of 7.18%.
Kofax® Limited (NASDAQ:KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, announced that a top European bank that operates globally expanded its investment in Kofax solutions, licensing the Kofax Mobile Capture™ Platform. Kofax Ltd (NASDAQ:KFX) stock opened at $8.68, in current trading session and currently is at $8.86, by gaining 0.23%. The 52 week range of $4.70 – $9.06. Company’s market capitalization is 809.53 million.
Vitesse Semiconductor (NASDAQ:VTSS) declined 8.51% after the company priced 7.462 million shares at $3.35 per share. Vitesse Semiconductor (NASDAQ:VTSS) stock is currently trading at $3.40. The EPS of the stock is -0.46. Company’s market capitalization is 199.63 million.
China XD Plastics Company Limited (NASDAQ:CXDC), one of China’s leading specialty chemical players engaged in the development, manufacture and sale of polymer composite materials primarily for automotive applications, on 14 may announced its financial results for the first quarter ended March 31,2014. Gross profit was $46.6 million, an increase of 59.6% from $29.2 million in the first quarter of 2013. China XD Plastics Co Ltd (NASDAQ:CXDC) stock opened the session at $10.49, and now is at $9.79. The 52 week range of the China XD Plastics Co Ltd (NASDAQ:CXDC) stock remained $3.99 – $13.24 and the day range was $9.77 – $10.76.
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) was upgraded by research analysts at JMP Securities from a “market perform” rating to an “outperform” rating in a report released on Tuesday, TheFlyOnTheWall.com reports. The firm currently has a $13.00 price target on the stock. JMP Securities’ price target would suggest a potential upside of 78.30% from the company’s current price. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock opened today at $7.25 and is currently trading at $6.97. The stock showed a positive weekly performance of 169.00%.